Minerva Neurosciences, Inc. (NERV) › Shareholders' EquityMinerva Neurosciences, Inc. (NERV) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2012: $19.0K2013: $20.18M2014: $51.50M2015: $55.32M2016: $105.98M2017: $131.60M2018: $90.26M2019: $27.78M2020: $52.66M2021: $7.98M2022: -$20.02M2023: -$28.46M2024: -$25.69M2025: -$140.75M-$140.75M2012Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$140.75M-447.8%2024-$25.69M+9.7%2023-$28.46M-42.1%2022-$20.02M-351.1%2021$7.98M-84.9%2020$52.66M+89.6%2019$27.78M-69.2%2018$90.26M-31.4%2017$131.60M+24.2%2016$105.98M+91.6%2015$55.32M+7.4%2014$51.50M+155.2%2013$20.18M+106002.3%2012$19.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share